ARID1A and ovarian clear cell cancer: In the same way, small molecule inhibitors of the bromodomain and extra terminal domain (BET) family of proteins specifically inhibit proliferation of ARID1A mutated cell lines, both in vitro and in ovarian clear-cell cancer xenografts and patient-derived xenograft models.